Marker Therapeutics
Develops non-genetically modified multi-antigen T-cell therapies for lymphoma, pancreatic cancer, AML, and MDS.
$1.37
After-hours close+0.02 (+1.75%)
At close$1.35(−7.53%)
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$0.12 | — | — |
| Aug 2026 | −$0.25 | −$0.09 | +64.0% |
| May 2026 | −$0.18 | −$0.16 | +11.1% |
| Mar 2026 | −$0.21 | −$0.04 | +81.0% |
| Nov 2025 | −$0.36 | −$0.12 | +66.7% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | |||
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Mar 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Mar 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Mar 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Mar 2017 | |||
| Nov 2016 | |||
| Aug 2016 | |||
| May 2016 | |||
| Apr 2016 | |||
| Nov 2015 | |||
| Aug 2015 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise |
|---|---|---|---|---|---|---|
| Nov 12, 2026 | −$0.12 | — | — | $2.1M | — | — |
| Aug 14, 2026 | −$0.25 | −$0.09 | +64.0% | $694.0K | — | — |
| May 15, 2026 | −$0.18 | −$0.16 | +11.1% | $783.9K | — | — |
| Mar 18, 2026 | −$0.21 | −$0.04 | +81.0% | $682.1K | $1.1M | +61.3% |
| Nov 13, 2025 | −$0.36 | −$0.12 | +66.7% | $723.0K | $1.2M | +70.5% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | ||||||
| Aug 14, 2025 | ||||||
| May 21, 2025 | ||||||
| Mar 31, 2025 | ||||||
| Nov 14, 2024 | ||||||
| Aug 14, 2024 | ||||||
| May 15, 2024 | ||||||
| Mar 26, 2024 | ||||||
| Nov 9, 2023 | ||||||
| Aug 14, 2023 | ||||||
| May 16, 2023 | ||||||
| Mar 22, 2023 | ||||||
| Nov 10, 2022 | ||||||
| Aug 11, 2022 | ||||||
| May 13, 2022 | ||||||
| Mar 17, 2022 | ||||||
| Nov 10, 2021 | ||||||
| Aug 10, 2021 | ||||||
| May 12, 2021 | ||||||
| Mar 9, 2021 | ||||||
| Nov 9, 2020 | ||||||
| Aug 10, 2020 | ||||||
| May 11, 2020 | ||||||
| Mar 12, 2020 | ||||||
| Nov 12, 2019 | ||||||
| Aug 8, 2019 | ||||||
| May 9, 2019 | ||||||
| Mar 15, 2019 | ||||||
| Nov 13, 2018 | ||||||
| Aug 9, 2018 | ||||||
| May 15, 2018 | ||||||
| Mar 23, 2018 | ||||||
| Nov 14, 2017 | ||||||
| Aug 7, 2017 | ||||||
| May 5, 2017 | ||||||
| Mar 14, 2017 | ||||||
| Nov 4, 2016 | ||||||
| Aug 15, 2016 | ||||||
| May 16, 2016 | ||||||
| Apr 14, 2016 | ||||||
| Nov 16, 2015 | ||||||
| Aug 14, 2015 | ||||||